Infectious Diseases News and Research

RSS

Cerus to support ongoing development of INTERCEPT red cell system

Cerus Corporation announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells.

19 Aug 2011

Temple University, URMC partner to translate novel medical research into new drugs

The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have announced a partnership that will help translate novel medical research into new drugs for treating diseases.

19 Aug 2011

Medical research funding boost in UK

Health researchers in Cambridge have been awarded £114.5m to develop and translate new scientific discoveries into medicines and treatments. The funds come as a part of a five-year £800m investment by the National Institute for Health Research (NIHR).

18 Aug 2011

Mosquitoes fast to develop resistance against insecticide-treated bed nets

According to a study from Senegal mosquitoes are quick to develop resistance to insecticide-treated nets. This has raised concerns that a leading method of preventing the disease may be less effective than previously thought.

18 Aug 2011

AHRQ awards Johns Hopkins Evidence-based Practice Center $475,000 for study on effective wound care

An estimated $25 billion is spent annually on treating chronic wounds on patients in the United States. These chronic wounds deeply affect the quality of life of more than six million people who have them. The most common types of chronic skin wounds and skin ulcers are related to venous disease (conditions related to or caused by veins that become diseased or abnormal).

18 Aug 2011

Insight into how HIV reservoirs may form

Much like cities organize contingency plans and supplies for emergencies, chronic infectious diseases like HIV form reservoirs that ensure their survival in adverse conditions. But these reservoirs-small populations of viruses or bacteria of a specific type that persist despite attack by the immune system or drug treatment-are not always well understood.

18 Aug 2011

New collaboration for development of new malaria vaccine

"The Infectious Disease Research Institute (IDRI) today announced a new Memorandum of Understanding with the United States Agency for International Development (USAID), focused on support of a collaboration with the Walter Reed Army Institute of Research (WRAIR) for the development of a new vaccine against malaria," an IDRI press release states.

18 Aug 2011

Researchers isolate 17 novel antibodies against HIV

A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.

18 Aug 2011

GeoVax receives NIH-NIAID grant for HIV/AIDS vaccine program

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.

17 Aug 2011

Methodist, Philips partner to develop new imaging technology for infectious diseases

The Methodist Hospital Research Institute and Philips Healthcare are collaborating to develop new imaging technology that could be used to help identify the start -- and cause -- of an infectious disease epidemic.

From Philips Healthcare 17 Aug 2011

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).

17 Aug 2011

Study finds broadest immune response from LAIV nasal spray vaccines for children

Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, inhaled through a nasal spray or provided through one dose of each in any order, according to researchers funded by the National Institutes of Health.

17 Aug 2011

State roundup: Health insurance ruling reverberates; Fla. to accept some health law funds; California's aging issues

The state has returned millions in health reform dollars for child and elder care programs, among other things. But on Monday, HHS awarded the Sunshine State $1.26 million in ACA money to bolster efforts to report and combat infectious diseases.

17 Aug 2011

Researchers identify oncoprotein that allows MCV virus to trigger Merkel Cell Carcinoma

Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform healthy cells into a rare but deadly skin cancer called Merkel Cell Carcinoma.

16 Aug 2011

Study confirms presence of bacteria linked with early childhood caries in infant saliva

New parents have one more reason to pay attention to the oral health of their toothless babies. A recent University of Illinois study confirms the presence of bacteria associated with early childhood caries (ECC) in infant saliva.

16 Aug 2011

Viewpoints: Health reform 'tax' vs. 'penalty'; super committee forecast; boomer tsunami

In a foolhardy indulgence of partisan ideology, Gov. Sam Brownback of Kansas is returning a $31.5 million federal grant that would have made his state a leader in technology development for the new federal health care law. … He joins other Republican governors willing to sell their constituents short in grandstanding against the health care law from statehouse pulpits.

16 Aug 2011

New ‘cure-all’ antiviral method discovered

In a new development that could transform how viral infections are treated, a team of researchers at MIT’s Lincoln Laboratory has designed a drug that can identify cells that have been infected by any type of virus, then kill those cells to terminate the infection.

15 Aug 2011

Kineta's next generation antiviral program receives $2.8 million NIH SBIR grant

Kineta, Inc. announced today its next generation antiviral program has received a 2.8 million dollar grant from the National Institute of Allergy and Infectious Disease, a part of the National Institutes of Health (NIH). Awarded under the Small Business Innovation Research (SBIR) program, the prestigious phase two grant will provide on-going support for Kineta's work on a new class of antiviral drugs targeting an array of global, deadly viruses.

12 Aug 2011

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed a pre-IND (Investigational New Drug) meeting with the FDA on August 10 to discuss the development plan for ADXS-PSA, a construct for the treatment of prostate cancer.

12 Aug 2011

New technique can help develop HIV vaccines

Researchers have traced in detail how certain powerful HIV neutralizing antibodies evolve, a finding that generates vital clues to guide the design of a preventive HIV vaccine, according to a study appearing in Science Express this week.

12 Aug 2011

Infectious Diseases News and Research

Cerus to support ongoing development of INTERCEPT red cell system

Temple University, URMC partner to translate novel medical research into new drugs

Medical research funding boost in UK

Mosquitoes fast to develop resistance against insecticide-treated bed nets

AHRQ awards Johns Hopkins Evidence-based Practice Center $475,000 for study on effective wound care

Insight into how HIV reservoirs may form

New collaboration for development of new malaria vaccine

Researchers isolate 17 novel antibodies against HIV

GeoVax receives NIH-NIAID grant for HIV/AIDS vaccine program

Methodist, Philips partner to develop new imaging technology for infectious diseases

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Study finds broadest immune response from LAIV nasal spray vaccines for children

State roundup: Health insurance ruling reverberates; Fla. to accept some health law funds; California's aging issues

Researchers identify oncoprotein that allows MCV virus to trigger Merkel Cell Carcinoma

Study confirms presence of bacteria linked with early childhood caries in infant saliva

Viewpoints: Health reform 'tax' vs. 'penalty'; super committee forecast; boomer tsunami

New ‘cure-all’ antiviral method discovered

Kineta's next generation antiviral program receives $2.8 million NIH SBIR grant

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

New technique can help develop HIV vaccines

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News